Ann: FDA Supports Accelerated Approval Pathway for Heart Failure, page-546

Most here agree that the answer to that question is going to be a big, fat "it depends", or "depended" if talking in the past tense. Those paying attention to the communications, as vague as they can be, knew what near-term announcements could entail, positive or negative.

In my opinion... Moving forward a BLA resubmission can put this over a dollar and if it's a quick approval that catches shorts of guard, say a few weeks into a class 1 resubmission that already had a shorter timeline, this could easily go into the multiple dollars.

In my opinion... A submission for Heart Failure AA would have the same effect, but a much larger response on approval considering the size of the market.

So that 86c in 3 weeks - yes a lot of people here recognised the potential.

Could it happen again? It depends.